On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its mid-December bear gap, after which it hit a Jan. 17, 52-week low of $78.17 amid ...

Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.A new study ...

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

Novo Nordisk stock reversed a three-day downtrend Wednesday after the weight-loss drugs kingpin leaned on Ozempic for a ...

As Netflix's Celebrity Bear Hunt drops, we take a look at one of the famous faces that has taken part - model and younger ...

Lottie Moss is one of the 12 celebrities taking part in Bear Grylls' new Netflix series, Celebrity Bear Hunt, and ahead of ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

In the wake of the trade, which left Mavericks fans stunned and disappointed, having given up a 25-year-old megastar for a 31-year old without a hefty future return in place, it was reported by ESPN ...

Model Lottie Moss is one of the 12 celebrities that have been turned into prey in the Costa Rican jungle by adventurer Bear ...

Among the stars is Lottie Moss, the stunning model and half-sister to fashion icon Kate Moss. As fans gear up to binge-watch ...

Novo Nordisk stock gained, lifted by strong sales growth and guidance from the maker of Wegovy and Ozempic. Shares in Novo, one of Europe's largest listed companies, advanced nearly 3% in Denmark. Dig ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...